📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia (2024)

First Author: Wei J

Attributed to: Other infectious diseases of global public health significance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2024.106161

PubMed Identifier: 38663754

Publication URI: http://europepmc.org/abstract/MED/38663754

Type: Journal Article/Review

Parent Publication: Journal of Infection

Issue: 6

ISSN: 0163-4453